Presymptomatic testing in myotonic dystrophy: genetic counselling approaches

Por Fokstuen, S., Myring, J., Evans, C., Harper, P.
Publicado em 2001

Mutation analysis of 184 cystic fibrosis families in Wales.

Por Cheadle, J, Myring, J, al-Jader, L, Meredith, L
Publicado em 1992

Eight years' experience of direct molecular testing for myotonic dystrophy in Wales

Por Fokstuen, S., Myring, J., Meredith, L., Ravine, D., Harper, P.
Publicado em 2001

Specific molecular prenatal diagnosis for the CTG mutation in myotonic dystrophy.

Por Myring, J, Meredith, A L, Harley, H G, Kohn, G, Norbury, G, Harper, P S, Shaw, D J
Publicado em 1992

Cataract and myotonic dystrophy: the role of molecular diagnosis.

Por Reardon, W, MacMillan, J C, Myring, J, Harley, H G, Rundle, S A, Beck, L, Harper, P S, Shaw, D J
Publicado em 1993

Size of the unstable CTG repeat sequence in relation to phenotype and parental transmission in myotonic dystrophy.

Por Harley, H G, Rundle, S A, MacMillan, J C, Myring, J, Brook, J D, Crow, S, Reardon, W, Fenton, I, Shaw, D J, Harper, P S
Publicado em 1993

BRCA1 and BRCA2 in breast cancer families from Wales: moderate mutation frequency and two recurrent mutations in BRCA1.

Por Lancaster, J. M., Carney, M. E., Gray, J., Myring, J., Gumbs, C., Sampson, J., Wheeler, D., France, E., Wiseman, R., Harper, P., Futreal, P. A.
Publicado em 1998